NICE recommends Blenrep for relapsed multiple myeloma

NICE seeks feedback on new EQ-5D-5L value set

The Danish Association of the Pharmaceutical Industry (LIF) warns: MFN could intensify pressure on Denmark’s drug reimbursement system.

TLV publishes health economic assessment of Blenrep

Socialstyrelsen establishes SweCan to coordinate cancer innovation

The Danish Association of the Pharmaceutical Industry (LIF) warns: medicines will come later to Europe and Denmark

Sweden’s regions broaden use of tripartite negotiations

Reimbursement can change even when the medicines do not – KELA revise reimbursement status for severe mental health disorders

NICE sets a dedicated fertility pathway for endometriosis

NICE and MHRA align reviews to speed access